Recent News

By Category: Policy & Initiatives

The Evolution of Bird Flu, and the Race to Keep Up

(New York Times) On May 20, a 10-year-old girl in rural Cambodia got a fever. Five days later, she was admitted to a hospital, and after two days of intensive care she was dead. The girl was the most recent documented victim of the influenza virus H5N1, a strain that has caused 606 known human  Read More »

Lawmakers want CDC info on bioterror lab

(USA TODAY) The Centers for Disease Control and Prevention is considering having U.S. Army scientists or another outside agency inspect its bioterror labs in the wake of a USA TODAY report this month. The agency plans to install safety equipment to address fire code violations from December 2010 that could trap workers in an emergency,  Read More »

Debate over H5N1 fatality rate flares again

(CIDRAP News) In the latest chapter in an ongoing debate over the true case-fatality ratio (CFR) for human H5N1 influenza infections, a group of leading flu experts has written a Science article rejecting the idea that millions of H5N1 infections have gone undetected. The debate was sparked by the controversy over publication of two studies  Read More »

H5N1: What kind of oversight is best for bird flu research?

(Los Angeles Times) The upshot of months of controversy over whether to publish research that used the H5N1 avian flu virus — experiments in which scientists engineered forms of the bug that could spread through the air to infect mammals — was that scientists got to publish their work in full in a special issue  Read More »

Long-Awaited Bird-Flu Study Shows It’s Still a Threat

(Global Security Newswire) WASHINGTON – Researchers published a batch of controversial studies on bird flu on Thursday, demonstrating that H5N1 is still dangerous to humanity and closing a chapter in a still-evolving debate over censoring scientific research. Commentaries questioned the wisdom of an unprecedented U.S. government request to delay the research, while experts debated whether  Read More »